Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Insulin Glargine and Sitagliptin in Patients With Type 2 Diabetes Not Adequately Controlled by a Previous Treatment With Metformin and Either Insulin Glargine or Sitagliptin

NCT00851903 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00851903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00851903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Insulin Glargine and Sitagliptin in Patients With Type 2 Diabetes Not Adequately Controlled by a Previous Treatment With Metformin and Either Insulin Glargine or Sitagliptin
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
September 30, 2011
Enrollment
112 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2